Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: A candidate gene association study

Annals of Surgery

Volumn 259, Issue 1, 2014, Pages 179-185

  Thompson, Callie M ^a   Holden, Tarah D ^a   Rona, Gail ^a   Laxmanan, Balaji ^a   Black, R Anthony ^a   O'Keefe, Grant E ^a   Wurfel, Mark M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic variation; Polymorphism; Sepsis; Toll like receptor; Trauma

Indexed keywords

GENOMIC DNA; TOLL LIKE RECEPTOR 1;

ABDOMINAL INJURY; ADULT; ARTICLE; BLUNT TRAUMA; DISEASE PREDISPOSITION; ESCHERICHIA COLI; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GRAM POSITIVE INFECTION; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INJURY; INJURY SEVERITY; INNATE IMMUNITY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; THORAX INJURY; TRAUMATIC BRAIN INJURY; YOUNG ADULT;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEPSIS; TOLL-LIKE RECEPTOR 1; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84891626934     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31828538e8     Document Type: Article

References (32)

1. Wurfel MM, GordonAC,Holden TD, et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med. 2008;178:710-720.
2. O'Keefe GE, Hybki DL, Munford RS. The G->a single nucleotide polymorphism at the -308 position in the tumor necrosis factor-Alpha promoter increases the risk for severe sepsis after trauma. J Trauma. 2002;52:817-825.
3. Shalhub S, Pham TN, Gibran NS, et al. Tumor necrosis factor gene variation and the risk of mortality after burn injury: A cohort study. J Burn Care Res. 2009;30:105-111.
4. Barber RC, Aragaki CC, Rivera-Chavez FA, et al. TLR4 and TNF-Alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet. 2004;41:808-813.
5. De Maio A, Mooney ML, Matesic LE, et al. Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock. 1998;10:319-323.
6. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-Alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24:381-384.
7. Zeng L, Gu W, Zhang AQ, et al. A functional variant of lipopolysaccharide binding protein predisposes to sepsis and organ dysfunction in patients with major trauma. Ann Surg. 2012;255:147-157.
8. Shalhub S, Junker CE, Imahara SD, et al.Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: A cohort study. J Trauma. 2009;66:115-122.
9. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010.
10. Lafferty EI, Qureshi ST, Schnare M. The role of toll-like receptors in acute and chronic lung inflammation. J Inflamm (Lond). 2010;7:57.
11. Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: Role of injury severity and tissue hypoperfusion. Crit Care. 2009;13:R174.
12. Yang R, Harada T, Mollen KP, et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med. 2006;12:105-114.
13. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol. 2002;169:10-14.
14. Shimizu T, Kida Y, Kuwano K. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2. Immunology. 2007;121:473-483.
15. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
16. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
17. Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal. 1999;14:143-149.
18. Skol AD, Scott LJ, Abecasis GR, et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209-213.
19. Wyllie DH, Kiss-Toth E, Visintin A, et al. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol. 2000;165:7125-7132.
20. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002;30:S1-S11.
21. Heron M. Deaths: Leading causes for 2007. Natl Vital Stat Rep. 2011;59:1-95.
22. Wafaisade A, Lefering R, Bouillon B, et al. Epidemiology and risk factors of sepsis after multiple trauma: An analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med. 2011;39:621-628.
23. Seabury CM, Cargill EJ, Womack JE. Sequence variability and protein domain architectures for bovine Toll-like receptors 1, 5, and 10. Genomics. 2007;90:502-515.
24. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249.
25. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863-874.
26. Wong SH, Gochhait S, Malhotra D, et al. Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog. 2010;6:e1000979.
27. Hawn TR, Scholes D, Li SS, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One. 2009;4: E5990.
28. Pino-Yanes M, Corrales A, Casula M, et al. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One. 2010;5:e13759.
29. Hamann L, Bedu-Addo G, Eggelte TA, et al. The toll-like receptor 1 variant S248N influences placental malaria. Infect Genet Evol. 2010;10:785-789.
30. Lee JS, Park HK, Suh JS, et al. Toll-like receptor 1 gene polymorphisms in childhood IgA nephropathy: A case-control study in the Korean population. Int J Immunogenet. 2011;38:133-138.
31. KormannMS, DepnerM, Hartl D, et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol. 2008;122:86-92, 92. e81- e88.
32. Chen YC, Giovannucci E, Kraft P, et al. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1982-1989.